Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 5Colonic Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Brain Neoplasms 4Ovarian Neoplasms 3Melanoma 3Glioblastoma 3Breast Neoplasms 3Advanced Solid Tumor 3Stomach Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Gliosarcoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms, Male 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Spinal Cord Neoplasms 1Sezary Syndrome 1Rhabdoid Tumor 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Neoplasms, Plasma Cell 1

Interventions

Filgrastim 8Temozolomide 6Carboplatin 6Granulocyte Colony-Stimulating Factor 4Etoposide 4O(6)-benzylguanine 3Busulfan 3Vorinostat 2Topotecan 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Irinotecan 2Ifosfamide 2Cyclophosphamide 2veliparib 1trioctyl phosphine oxide 1sodium thiosulfate 1sargramostim 1romidepsin 1pomalidomide 1pazopanib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1imetelstat 1exatecan 1etoposide phosphate 1emvododstat 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Optic Nerve Glioma × cediranib × Clear all
NCT00326664 2016-03-07

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

National Cancer Institute (NCI)

Phase 1 Completed
55 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Spinal Cord Neoplasms, Rhabdoid Tumor, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡